353 related articles for article (PubMed ID: 18266088)
41. BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury.
Zeisberg M; Hanai J; Sugimoto H; Mammoto T; Charytan D; Strutz F; Kalluri R
Nat Med; 2003 Jul; 9(7):964-8. PubMed ID: 12808448
[TBL] [Abstract][Full Text] [Related]
42. Transforming growth factor-beta/connective tissue growth factor axis in the kidney.
Qi W; Chen X; Poronnik P; Pollock CA
Int J Biochem Cell Biol; 2008; 40(1):9-13. PubMed ID: 17300978
[TBL] [Abstract][Full Text] [Related]
43. Intermedin is upregulated and attenuates renal fibrosis by inhibition of oxidative stress in rats with unilateral ureteral obstruction.
Qiao X; Wang L; Wang Y; Zhao N; Zhang R; Han W; Peng Z
Nephrology (Carlton); 2015 Nov; 20(11):820-31. PubMed ID: 26014968
[TBL] [Abstract][Full Text] [Related]
44. Circulating bone morphogenetic protein 1-3 isoform increases renal fibrosis.
Grgurevic L; Macek B; Healy DR; Brault AL; Erjavec I; Cipcic A; Grgurevic I; Rogic D; Galesic K; Brkljacic J; Stern-Padovan R; Paralkar VM; Vukicevic S
J Am Soc Nephrol; 2011 Apr; 22(4):681-92. PubMed ID: 21415150
[TBL] [Abstract][Full Text] [Related]
45. HuangQi Decoction Ameliorates Renal Fibrosis via TGF-β/Smad Signaling Pathway In Vivo and In Vitro.
Zhao J; Wang L; Cao AL; Jiang MQ; Chen X; Wang Y; Wang YM; Wang H; Zhang XM; Peng W
Cell Physiol Biochem; 2016; 38(5):1761-74. PubMed ID: 27161221
[TBL] [Abstract][Full Text] [Related]
46. Astragaloside IV inhibits renal tubulointerstitial fibrosis by blocking TGF-β/Smad signaling pathway in vivo and in vitro.
Wang L; Chi YF; Yuan ZT; Zhou WC; Yin PH; Zhang XM; Peng W; Cai H
Exp Biol Med (Maywood); 2014 Oct; 239(10):1310-24. PubMed ID: 24879422
[TBL] [Abstract][Full Text] [Related]
47. Gremlin-mediated decrease in bone morphogenetic protein signaling promotes pulmonary fibrosis.
Myllärniemi M; Lindholm P; Ryynänen MJ; Kliment CR; Salmenkivi K; Keski-Oja J; Kinnula VL; Oury TD; Koli K
Am J Respir Crit Care Med; 2008 Feb; 177(3):321-9. PubMed ID: 17975199
[TBL] [Abstract][Full Text] [Related]
48. Connective tissue growth factor (CTGF) acts as a downstream mediator of TGF-beta1 to induce mesenchymal cell condensation.
Song JJ; Aswad R; Kanaan RA; Rico MC; Owen TA; Barbe MF; Safadi FF; Popoff SN
J Cell Physiol; 2007 Feb; 210(2):398-410. PubMed ID: 17111364
[TBL] [Abstract][Full Text] [Related]
49. Activin-like kinase 3 is important for kidney regeneration and reversal of fibrosis.
Sugimoto H; LeBleu VS; Bosukonda D; Keck P; Taduri G; Bechtel W; Okada H; Carlson W; Bey P; Rusckowski M; Tampe B; Tampe D; Kanasaki K; Zeisberg M; Kalluri R
Nat Med; 2012 Feb; 18(3):396-404. PubMed ID: 22306733
[TBL] [Abstract][Full Text] [Related]
50. The role of epithelial-to-mesenchymal transition in renal fibrosis.
Zeisberg M; Kalluri R
J Mol Med (Berl); 2004 Mar; 82(3):175-81. PubMed ID: 14752606
[TBL] [Abstract][Full Text] [Related]
51. Negative regulators of TGF-β1 signaling in renal fibrosis; pathological mechanisms and novel therapeutic opportunities.
Gifford CC; Tang J; Costello A; Khakoo NS; Nguyen TQ; Goldschmeding R; Higgins PJ; Samarakoon R
Clin Sci (Lond); 2021 Jan; 135(2):275-303. PubMed ID: 33480423
[TBL] [Abstract][Full Text] [Related]
52. Transforming growth factor-beta pathway is activated in cholecystolithiasis.
Köninger J; di Mola FF; Di Sebastiano P; Gardini A; Brigstock DR; Innocenti P; Büchler MW; Friess H
Langenbecks Arch Surg; 2005 Feb; 390(1):21-8. PubMed ID: 15702358
[TBL] [Abstract][Full Text] [Related]
53. Role of connective tissue growth factor in the pathogenesis of conjunctival scarring in ocular cicatricial pemphigoid.
Razzaque MS; Foster CS; Ahmed AR
Invest Ophthalmol Vis Sci; 2003 May; 44(5):1998-2003. PubMed ID: 12714635
[TBL] [Abstract][Full Text] [Related]
54. Exploring the connection between chronic renal fibrosis and bone morphogenic protein-7.
Kalluri R; Zeisberg M
Histol Histopathol; 2003 Jan; 18(1):217-24. PubMed ID: 12507301
[TBL] [Abstract][Full Text] [Related]
55. Role of connective growth factor in plasminogen activator inhibitor-1 and fibronectin expression induced by transforming growth factor beta1 in renal tubular cells.
Zhang C; Meng XF; Zhu ZH; Yang X; Deng AG
Chin Med J (Engl); 2004 Jul; 117(7):990-6. PubMed ID: 15265370
[TBL] [Abstract][Full Text] [Related]
56. Connective tissue growth factor mediates the profibrotic effects of transforming growth factor-beta produced by tubular epithelial cells in response to high glucose.
Kobayashi T; Inoue T; Okada H; Kikuta T; Kanno Y; Nishida T; Takigawa M; Sugaya T; Suzuki H
Clin Exp Nephrol; 2005 Jun; 9(2):114-21. PubMed ID: 15980944
[TBL] [Abstract][Full Text] [Related]
57. Therapeutic targets for treating fibrotic kidney diseases.
Lee SY; Kim SI; Choi ME
Transl Res; 2015 Apr; 165(4):512-30. PubMed ID: 25176603
[TBL] [Abstract][Full Text] [Related]
58. Reduction in connective tissue growth factor by antisense treatment ameliorates renal tubulointerstitial fibrosis.
Yokoi H; Mukoyama M; Nagae T; Mori K; Suganami T; Sawai K; Yoshioka T; Koshikawa M; Nishida T; Takigawa M; Sugawara A; Nakao K
J Am Soc Nephrol; 2004 Jun; 15(6):1430-40. PubMed ID: 15153554
[TBL] [Abstract][Full Text] [Related]
59. [Expression of connective tissue growth factor in renal interstitial fibrosis after ureteral obstruction and effects of rapamycin thereupon: experiment with rats].
Sun B; Xing CY; He WC; Wang NN; Yu XB; Zhao XF; Qian J; Yang JW; Liu J; Wang XY
Zhonghua Yi Xue Za Zhi; 2007 Feb; 87(8):562-6. PubMed ID: 17459212
[TBL] [Abstract][Full Text] [Related]
60. Bone morphogenetic proteins in development and homeostasis of kidney.
Simic P; Vukicevic S
Cytokine Growth Factor Rev; 2005 Jun; 16(3):299-308. PubMed ID: 15923134
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
